Correlation between copy number variation genes (focal events) and selected clinical features
Brain Lower Grade Glioma (Primary solid tumor)
17 October 2014  |  analyses__2014_10_17
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between copy number variation genes (focal events) and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C1HQ3XSK
Overview
Introduction

This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.

Summary

Testing the association between copy number variation 52 focal events and 8 clinical features across 430 patients, 31 significant findings detected with Q value < 0.25.

  • amp_1q32.1 cnv correlated to 'AGE'.

  • amp_3q26.33 cnv correlated to 'Time to Death'.

  • amp_7p11.2 cnv correlated to 'Time to Death' and 'AGE'.

  • amp_7q31.2 cnv correlated to 'AGE'.

  • amp_7q32.3 cnv correlated to 'AGE'.

  • amp_10p15.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_12q14.1 cnv correlated to 'Time to Death'.

  • amp_19p13.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_19p13.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_1p36.32 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_1p32.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_5q34 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_6p25.3 cnv correlated to 'Time to Death'.

  • del_6q22.31 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.

  • del_6q24.3 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.

  • del_9p23 cnv correlated to 'Time to Death'.

  • del_9p21.3 cnv correlated to 'Time to Death' and 'AGE'.

  • del_10q26.3 cnv correlated to 'Time to Death',  'AGE', and 'HISTOLOGICAL.TYPE'.

  • del_11p15.5 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_14q24.3 cnv correlated to 'Time to Death'.

  • del_19q13.41 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_19q13.42 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_22q13.31 cnv correlated to 'Time to Death'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 52 focal events and 8 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 31 significant findings detected.

Clinical
Features
Time
to
Death
AGE GENDER KARNOFSKY
PERFORMANCE
SCORE
HISTOLOGICAL
TYPE
RADIATIONS
RADIATION
REGIMENINDICATION
RACE ETHNICITY
nCNV (%) nWild-Type logrank test Wilcoxon-test Fisher's exact test Wilcoxon-test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test
del 10q26 3 123 (29%) 307 2.57e-11
(1.07e-08)
8.01e-06
(0.00323)
0.0416
(1.00)
0.158
(1.00)
4e-05
(0.0157)
0.896
(1.00)
0.223
(1.00)
0.787
(1.00)
amp 7p11 2 104 (24%) 326 1.73e-08
(7.14e-06)
1.62e-08
(6.71e-06)
0.259
(1.00)
0.115
(1.00)
0.0212
(1.00)
0.334
(1.00)
0.111
(1.00)
1
(1.00)
del 1p36 32 177 (41%) 253 0.0987
(1.00)
2.33e-06
(0.000955)
0.622
(1.00)
0.691
(1.00)
1e-05
(0.00402)
0.0401
(1.00)
0.3
(1.00)
1
(1.00)
del 1p32 3 168 (39%) 262 0.00802
(1.00)
6.32e-06
(0.00256)
0.766
(1.00)
0.559
(1.00)
1e-05
(0.00402)
0.00484
(1.00)
0.491
(1.00)
1
(1.00)
del 6q22 31 62 (14%) 368 2.97e-06
(0.00121)
0.138
(1.00)
0.68
(1.00)
0.0681
(1.00)
1e-05
(0.00402)
0.309
(1.00)
0.141
(1.00)
1
(1.00)
del 6q24 3 66 (15%) 364 6.9e-05
(0.027)
0.461
(1.00)
0.346
(1.00)
0.0681
(1.00)
2e-05
(0.0079)
0.321
(1.00)
0.146
(1.00)
0.719
(1.00)
del 9p21 3 145 (34%) 285 3.99e-10
(1.65e-07)
2.82e-06
(0.00115)
0.355
(1.00)
0.00322
(1.00)
0.0026
(0.972)
0.0164
(1.00)
0.727
(1.00)
1
(1.00)
amp 1q32 1 36 (8%) 394 0.00395
(1.00)
4.22e-06
(0.00172)
1
(1.00)
0.0561
(1.00)
0.226
(1.00)
0.284
(1.00)
0.312
(1.00)
0.381
(1.00)
amp 3q26 33 18 (4%) 412 0.0004
(0.155)
0.141
(1.00)
0.342
(1.00)
0.157
(1.00)
0.00817
(1.00)
0.229
(1.00)
0.0645
(1.00)
1
(1.00)
amp 7q31 2 148 (34%) 282 0.00151
(0.572)
7.85e-06
(0.00317)
0.0832
(1.00)
0.469
(1.00)
0.0377
(1.00)
0.616
(1.00)
0.0967
(1.00)
0.796
(1.00)
amp 7q32 3 153 (36%) 277 0.00395
(1.00)
1.51e-06
(0.000621)
0.0678
(1.00)
0.608
(1.00)
0.0476
(1.00)
0.456
(1.00)
0.133
(1.00)
0.794
(1.00)
amp 10p15 3 57 (13%) 373 0.819
(1.00)
0.00144
(0.548)
0.153
(1.00)
0.111
(1.00)
0.00045
(0.175)
0.0354
(1.00)
1
(1.00)
0.249
(1.00)
amp 12q14 1 29 (7%) 401 4.72e-08
(1.94e-05)
0.00123
(0.472)
0.701
(1.00)
0.49
(1.00)
0.0211
(1.00)
0.477
(1.00)
0.228
(1.00)
1
(1.00)
amp 19p13 3 111 (26%) 319 0.572
(1.00)
0.0434
(1.00)
0.825
(1.00)
0.677
(1.00)
1e-05
(0.00402)
0.684
(1.00)
0.826
(1.00)
0.772
(1.00)
amp 19p13 2 104 (24%) 326 0.947
(1.00)
0.0115
(1.00)
0.428
(1.00)
0.476
(1.00)
1e-05
(0.00402)
1
(1.00)
0.762
(1.00)
0.555
(1.00)
del 5q34 53 (12%) 377 0.033
(1.00)
0.462
(1.00)
0.883
(1.00)
0.316
(1.00)
3e-05
(0.0118)
0.0727
(1.00)
0.442
(1.00)
0.706
(1.00)
del 6p25 3 41 (10%) 389 6.13e-06
(0.00249)
0.24
(1.00)
1
(1.00)
0.046
(1.00)
0.159
(1.00)
0.84
(1.00)
0.0933
(1.00)
0.655
(1.00)
del 9p23 122 (28%) 308 0.000463
(0.179)
0.00476
(1.00)
0.668
(1.00)
0.035
(1.00)
0.014
(1.00)
0.0248
(1.00)
0.675
(1.00)
1
(1.00)
del 11p15 5 84 (20%) 346 0.25
(1.00)
0.0627
(1.00)
0.0659
(1.00)
0.104
(1.00)
0.0001
(0.039)
0.454
(1.00)
0.729
(1.00)
1
(1.00)
del 14q24 3 100 (23%) 330 4.79e-05
(0.0188)
0.0269
(1.00)
0.206
(1.00)
0.222
(1.00)
0.105
(1.00)
0.778
(1.00)
0.241
(1.00)
1
(1.00)
del 19q13 41 227 (53%) 203 0.029
(1.00)
0.0186
(1.00)
0.771
(1.00)
0.66
(1.00)
1e-05
(0.00402)
0.721
(1.00)
0.79
(1.00)
0.611
(1.00)
del 19q13 42 234 (54%) 196 0.00143
(0.547)
0.114
(1.00)
1
(1.00)
0.786
(1.00)
1e-05
(0.00402)
1
(1.00)
0.759
(1.00)
0.449
(1.00)
del 22q13 31 61 (14%) 369 0.000612
(0.236)
0.00351
(1.00)
0.487
(1.00)
0.0985
(1.00)
0.00347
(1.00)
0.612
(1.00)
0.176
(1.00)
0.71
(1.00)
amp 1q22 37 (9%) 393 0.133
(1.00)
0.00149
(0.564)
0.864
(1.00)
0.328
(1.00)
0.438
(1.00)
0.394
(1.00)
0.527
(1.00)
0.38
(1.00)
amp 2p24 3 19 (4%) 411 0.393
(1.00)
0.508
(1.00)
0.485
(1.00)
0.632
(1.00)
0.0868
(1.00)
0.775
(1.00)
1
(1.00)
0.128
(1.00)
amp 4q12 25 (6%) 405 0.0682
(1.00)
0.427
(1.00)
1
(1.00)
0.515
(1.00)
0.00222
(0.832)
0.799
(1.00)
0.731
(1.00)
1
(1.00)
amp 8q24 13 83 (19%) 347 0.707
(1.00)
0.111
(1.00)
0.391
(1.00)
0.301
(1.00)
0.00154
(0.582)
0.88
(1.00)
0.779
(1.00)
1
(1.00)
amp 9q34 3 40 (9%) 390 0.61
(1.00)
0.894
(1.00)
0.0941
(1.00)
0.149
(1.00)
0.0382
(1.00)
0.538
(1.00)
0.0757
(1.00)
0.184
(1.00)
amp 11q24 1 73 (17%) 357 0.791
(1.00)
0.2
(1.00)
0.366
(1.00)
0.989
(1.00)
0.495
(1.00)
0.634
(1.00)
0.677
(1.00)
0.326
(1.00)
amp 12p13 32 57 (13%) 373 0.371
(1.00)
0.0659
(1.00)
0.0863
(1.00)
0.557
(1.00)
0.236
(1.00)
0.0354
(1.00)
0.893
(1.00)
0.708
(1.00)
amp 13q34 21 (5%) 409 0.396
(1.00)
0.748
(1.00)
0.656
(1.00)
0.113
(1.00)
0.557
(1.00)
1
(1.00)
0.651
(1.00)
0.564
(1.00)
amp 15q26 3 14 (3%) 416 0.0043
(1.00)
0.827
(1.00)
1
(1.00)
0.119
(1.00)
0.0743
(1.00)
0.501
(1.00)
1
(1.00)
0.414
(1.00)
amp 17q25 1 35 (8%) 395 0.0161
(1.00)
0.0926
(1.00)
1
(1.00)
0.699
(1.00)
0.189
(1.00)
0.67
(1.00)
0.158
(1.00)
0.368
(1.00)
amp xp11 22 35 (8%) 395 0.853
(1.00)
0.216
(1.00)
1
(1.00)
0.905
(1.00)
0.0352
(1.00)
0.126
(1.00)
0.201
(1.00)
1
(1.00)
amp xp11 22 50 (12%) 380 0.543
(1.00)
0.526
(1.00)
0.289
(1.00)
0.601
(1.00)
0.00091
(0.35)
0.353
(1.00)
0.752
(1.00)
1
(1.00)
del 1q43 23 (5%) 407 0.964
(1.00)
0.544
(1.00)
0.519
(1.00)
0.964
(1.00)
0.302
(1.00)
1
(1.00)
0.339
(1.00)
1
(1.00)
del 2q37 3 61 (14%) 369 0.693
(1.00)
0.0823
(1.00)
0.33
(1.00)
0.834
(1.00)
0.026
(1.00)
0.399
(1.00)
0.485
(1.00)
0.717
(1.00)
del 3p21 31 36 (8%) 394 0.214
(1.00)
0.992
(1.00)
1
(1.00)
0.00207
(0.779)
0.599
(1.00)
0.135
(1.00)
0.799
(1.00)
0.153
(1.00)
del 3q13 31 29 (7%) 401 0.00317
(1.00)
0.58
(1.00)
0.0319
(1.00)
0.452
(1.00)
0.693
(1.00)
0.159
(1.00)
1
(1.00)
0.307
(1.00)
del 3q29 35 (8%) 395 0.0204
(1.00)
0.542
(1.00)
0.287
(1.00)
0.247
(1.00)
0.188
(1.00)
0.513
(1.00)
0.63
(1.00)
0.631
(1.00)
del 4q34 3 114 (27%) 316 0.701
(1.00)
0.127
(1.00)
0.51
(1.00)
0.512
(1.00)
0.841
(1.00)
0.177
(1.00)
0.662
(1.00)
1
(1.00)
del 5p15 33 39 (9%) 391 0.925
(1.00)
0.202
(1.00)
0.313
(1.00)
0.0446
(1.00)
0.00464
(1.00)
0.00675
(1.00)
0.69
(1.00)
1
(1.00)
del 7p22 3 19 (4%) 411 0.192
(1.00)
0.943
(1.00)
1
(1.00)
0.751
(1.00)
0.916
(1.00)
1
(1.00)
0.37
(1.00)
1
(1.00)
del 8q24 3 23 (5%) 407 0.597
(1.00)
0.695
(1.00)
0.83
(1.00)
0.732
(1.00)
0.229
(1.00)
0.595
(1.00)
0.447
(1.00)
0.0498
(1.00)
del 11p15 1 60 (14%) 370 0.0671
(1.00)
0.305
(1.00)
0.161
(1.00)
0.0249
(1.00)
0.00106
(0.407)
0.392
(1.00)
0.708
(1.00)
1
(1.00)
del 12p13 1 33 (8%) 397 0.0148
(1.00)
0.71
(1.00)
0.858
(1.00)
0.469
(1.00)
0.0596
(1.00)
0.37
(1.00)
0.777
(1.00)
0.621
(1.00)
del 12q12 59 (14%) 371 0.787
(1.00)
0.683
(1.00)
0.323
(1.00)
0.539
(1.00)
0.00194
(0.731)
1
(1.00)
0.467
(1.00)
0.143
(1.00)
del 13q14 2 120 (28%) 310 0.0135
(1.00)
0.74
(1.00)
0.196
(1.00)
0.0092
(1.00)
0.0967
(1.00)
0.112
(1.00)
0.378
(1.00)
0.573
(1.00)
del 13q14 2 122 (28%) 308 0.0193
(1.00)
0.751
(1.00)
0.236
(1.00)
0.00949
(1.00)
0.0763
(1.00)
0.147
(1.00)
0.385
(1.00)
0.574
(1.00)
del 13q34 90 (21%) 340 0.0222
(1.00)
0.379
(1.00)
0.404
(1.00)
0.207
(1.00)
0.942
(1.00)
0.241
(1.00)
0.4
(1.00)
1
(1.00)
del 18q23 66 (15%) 364 0.725
(1.00)
0.0255
(1.00)
0.283
(1.00)
0.899
(1.00)
0.545
(1.00)
0.624
(1.00)
0.181
(1.00)
0.717
(1.00)
del xq21 1 58 (13%) 372 0.0625
(1.00)
0.0541
(1.00)
1
(1.00)
0.928
(1.00)
0.656
(1.00)
1
(1.00)
0.42
(1.00)
0.707
(1.00)
'amp_1q32.1' versus 'AGE'

P value = 4.22e-06 (Wilcoxon-test), Q value = 0.0017

Table S1.  Gene #2: 'amp_1q32.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
AMP PEAK 2(1Q32.1) MUTATED 36 53.1 (12.7)
AMP PEAK 2(1Q32.1) WILD-TYPE 393 42.1 (12.9)

Figure S1.  Get High-res Image Gene #2: 'amp_1q32.1' versus Clinical Feature #2: 'AGE'

'amp_3q26.33' versus 'Time to Death'

P value = 4e-04 (logrank test), Q value = 0.16

Table S2.  Gene #4: 'amp_3q26.33' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
AMP PEAK 4(3Q26.33) MUTATED 17 6 0.1 - 47.8 (12.0)
AMP PEAK 4(3Q26.33) WILD-TYPE 410 69 0.0 - 211.2 (16.0)

Figure S2.  Get High-res Image Gene #4: 'amp_3q26.33' versus Clinical Feature #1: 'Time to Death'

'amp_7p11.2' versus 'Time to Death'

P value = 1.73e-08 (logrank test), Q value = 7.1e-06

Table S3.  Gene #6: 'amp_7p11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
AMP PEAK 6(7P11.2) MUTATED 104 37 0.1 - 211.2 (14.0)
AMP PEAK 6(7P11.2) WILD-TYPE 323 38 0.0 - 182.3 (16.4)

Figure S3.  Get High-res Image Gene #6: 'amp_7p11.2' versus Clinical Feature #1: 'Time to Death'

'amp_7p11.2' versus 'AGE'

P value = 1.62e-08 (Wilcoxon-test), Q value = 6.7e-06

Table S4.  Gene #6: 'amp_7p11.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
AMP PEAK 6(7P11.2) MUTATED 104 49.6 (13.5)
AMP PEAK 6(7P11.2) WILD-TYPE 325 40.9 (12.5)

Figure S4.  Get High-res Image Gene #6: 'amp_7p11.2' versus Clinical Feature #2: 'AGE'

'amp_7q31.2' versus 'AGE'

P value = 7.85e-06 (Wilcoxon-test), Q value = 0.0032

Table S5.  Gene #7: 'amp_7q31.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
AMP PEAK 7(7Q31.2) MUTATED 148 47.0 (13.3)
AMP PEAK 7(7Q31.2) WILD-TYPE 281 40.9 (12.8)

Figure S5.  Get High-res Image Gene #7: 'amp_7q31.2' versus Clinical Feature #2: 'AGE'

'amp_7q32.3' versus 'AGE'

P value = 1.51e-06 (Wilcoxon-test), Q value = 0.00062

Table S6.  Gene #8: 'amp_7q32.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
AMP PEAK 8(7Q32.3) MUTATED 153 47.1 (13.1)
AMP PEAK 8(7Q32.3) WILD-TYPE 276 40.7 (12.8)

Figure S6.  Get High-res Image Gene #8: 'amp_7q32.3' versus Clinical Feature #2: 'AGE'

'amp_10p15.3' versus 'HISTOLOGICAL.TYPE'

P value = 0.00045 (Fisher's exact test), Q value = 0.17

Table S7.  Gene #11: 'amp_10p15.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
AMP PEAK 11(10P15.3) MUTATED 29 19 9
AMP PEAK 11(10P15.3) WILD-TYPE 130 88 155

Figure S7.  Get High-res Image Gene #11: 'amp_10p15.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'amp_12q14.1' versus 'Time to Death'

P value = 4.72e-08 (logrank test), Q value = 1.9e-05

Table S8.  Gene #14: 'amp_12q14.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
AMP PEAK 14(12Q14.1) MUTATED 29 13 1.2 - 80.0 (12.2)
AMP PEAK 14(12Q14.1) WILD-TYPE 398 62 0.0 - 211.2 (16.2)

Figure S8.  Get High-res Image Gene #14: 'amp_12q14.1' versus Clinical Feature #1: 'Time to Death'

'amp_19p13.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.004

Table S9.  Gene #18: 'amp_19p13.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
AMP PEAK 18(19P13.3) MUTATED 22 25 64
AMP PEAK 18(19P13.3) WILD-TYPE 137 82 100

Figure S9.  Get High-res Image Gene #18: 'amp_19p13.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'amp_19p13.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.004

Table S10.  Gene #19: 'amp_19p13.2' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
AMP PEAK 19(19P13.2) MUTATED 20 21 63
AMP PEAK 19(19P13.2) WILD-TYPE 139 86 101

Figure S10.  Get High-res Image Gene #19: 'amp_19p13.2' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_1p36.32' versus 'AGE'

P value = 2.33e-06 (Wilcoxon-test), Q value = 0.00095

Table S11.  Gene #22: 'del_1p36.32' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
DEL PEAK 1(1P36.32) MUTATED 176 46.4 (12.5)
DEL PEAK 1(1P36.32) WILD-TYPE 253 40.6 (13.3)

Figure S11.  Get High-res Image Gene #22: 'del_1p36.32' versus Clinical Feature #2: 'AGE'

'del_1p36.32' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.004

Table S12.  Gene #22: 'del_1p36.32' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 1(1P36.32) MUTATED 18 38 121
DEL PEAK 1(1P36.32) WILD-TYPE 141 69 43

Figure S12.  Get High-res Image Gene #22: 'del_1p36.32' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_1p32.3' versus 'AGE'

P value = 6.32e-06 (Wilcoxon-test), Q value = 0.0026

Table S13.  Gene #23: 'del_1p32.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
DEL PEAK 2(1P32.3) MUTATED 167 46.5 (12.9)
DEL PEAK 2(1P32.3) WILD-TYPE 262 40.7 (13.0)

Figure S13.  Get High-res Image Gene #23: 'del_1p32.3' versus Clinical Feature #2: 'AGE'

'del_1p32.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.004

Table S14.  Gene #23: 'del_1p32.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 2(1P32.3) MUTATED 12 35 121
DEL PEAK 2(1P32.3) WILD-TYPE 147 72 43

Figure S14.  Get High-res Image Gene #23: 'del_1p32.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_5q34' versus 'HISTOLOGICAL.TYPE'

P value = 3e-05 (Fisher's exact test), Q value = 0.012

Table S15.  Gene #31: 'del_5q34' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 10(5Q34) MUTATED 34 11 8
DEL PEAK 10(5Q34) WILD-TYPE 125 96 156

Figure S15.  Get High-res Image Gene #31: 'del_5q34' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_6p25.3' versus 'Time to Death'

P value = 6.13e-06 (logrank test), Q value = 0.0025

Table S16.  Gene #32: 'del_6p25.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 11(6P25.3) MUTATED 40 14 0.2 - 94.5 (17.5)
DEL PEAK 11(6P25.3) WILD-TYPE 387 61 0.0 - 211.2 (15.5)

Figure S16.  Get High-res Image Gene #32: 'del_6p25.3' versus Clinical Feature #1: 'Time to Death'

'del_6q22.31' versus 'Time to Death'

P value = 2.97e-06 (logrank test), Q value = 0.0012

Table S17.  Gene #33: 'del_6q22.31' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 12(6Q22.31) MUTATED 61 20 0.1 - 117.4 (15.0)
DEL PEAK 12(6Q22.31) WILD-TYPE 366 55 0.0 - 211.2 (16.1)

Figure S17.  Get High-res Image Gene #33: 'del_6q22.31' versus Clinical Feature #1: 'Time to Death'

'del_6q22.31' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.004

Table S18.  Gene #33: 'del_6q22.31' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 12(6Q22.31) MUTATED 40 11 11
DEL PEAK 12(6Q22.31) WILD-TYPE 119 96 153

Figure S18.  Get High-res Image Gene #33: 'del_6q22.31' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_6q24.3' versus 'Time to Death'

P value = 6.9e-05 (logrank test), Q value = 0.027

Table S19.  Gene #34: 'del_6q24.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 13(6Q24.3) MUTATED 65 20 0.0 - 130.8 (15.0)
DEL PEAK 13(6Q24.3) WILD-TYPE 362 55 0.1 - 211.2 (16.2)

Figure S19.  Get High-res Image Gene #34: 'del_6q24.3' versus Clinical Feature #1: 'Time to Death'

'del_6q24.3' versus 'HISTOLOGICAL.TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.0079

Table S20.  Gene #34: 'del_6q24.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 13(6Q24.3) MUTATED 41 12 13
DEL PEAK 13(6Q24.3) WILD-TYPE 118 95 151

Figure S20.  Get High-res Image Gene #34: 'del_6q24.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_9p23' versus 'Time to Death'

P value = 0.000463 (logrank test), Q value = 0.18

Table S21.  Gene #37: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 16(9P23) MUTATED 121 31 0.1 - 164.4 (17.3)
DEL PEAK 16(9P23) WILD-TYPE 306 44 0.0 - 211.2 (15.8)

Figure S21.  Get High-res Image Gene #37: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

'del_9p21.3' versus 'Time to Death'

P value = 3.99e-10 (logrank test), Q value = 1.7e-07

Table S22.  Gene #38: 'del_9p21.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 17(9P21.3) MUTATED 144 44 0.1 - 164.4 (14.8)
DEL PEAK 17(9P21.3) WILD-TYPE 283 31 0.0 - 211.2 (16.0)

Figure S22.  Get High-res Image Gene #38: 'del_9p21.3' versus Clinical Feature #1: 'Time to Death'

'del_9p21.3' versus 'AGE'

P value = 2.82e-06 (Wilcoxon-test), Q value = 0.0012

Table S23.  Gene #38: 'del_9p21.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
DEL PEAK 17(9P21.3) MUTATED 144 47.3 (13.7)
DEL PEAK 17(9P21.3) WILD-TYPE 285 40.8 (12.5)

Figure S23.  Get High-res Image Gene #38: 'del_9p21.3' versus Clinical Feature #2: 'AGE'

'del_10q26.3' versus 'Time to Death'

P value = 2.57e-11 (logrank test), Q value = 1.1e-08

Table S24.  Gene #39: 'del_10q26.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 18(10Q26.3) MUTATED 122 46 0.1 - 156.2 (14.6)
DEL PEAK 18(10Q26.3) WILD-TYPE 305 29 0.0 - 211.2 (16.4)

Figure S24.  Get High-res Image Gene #39: 'del_10q26.3' versus Clinical Feature #1: 'Time to Death'

'del_10q26.3' versus 'AGE'

P value = 8.01e-06 (Wilcoxon-test), Q value = 0.0032

Table S25.  Gene #39: 'del_10q26.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 429 43.0 (13.2)
DEL PEAK 18(10Q26.3) MUTATED 123 47.7 (13.8)
DEL PEAK 18(10Q26.3) WILD-TYPE 306 41.1 (12.5)

Figure S25.  Get High-res Image Gene #39: 'del_10q26.3' versus Clinical Feature #2: 'AGE'

'del_10q26.3' versus 'HISTOLOGICAL.TYPE'

P value = 4e-05 (Fisher's exact test), Q value = 0.016

Table S26.  Gene #39: 'del_10q26.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 18(10Q26.3) MUTATED 66 26 31
DEL PEAK 18(10Q26.3) WILD-TYPE 93 81 133

Figure S26.  Get High-res Image Gene #39: 'del_10q26.3' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_11p15.5' versus 'HISTOLOGICAL.TYPE'

P value = 1e-04 (Fisher's exact test), Q value = 0.039

Table S27.  Gene #40: 'del_11p15.5' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 19(11P15.5) MUTATED 45 23 16
DEL PEAK 19(11P15.5) WILD-TYPE 114 84 148

Figure S27.  Get High-res Image Gene #40: 'del_11p15.5' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_14q24.3' versus 'Time to Death'

P value = 4.79e-05 (logrank test), Q value = 0.019

Table S28.  Gene #47: 'del_14q24.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 26(14Q24.3) MUTATED 98 31 0.1 - 130.8 (16.7)
DEL PEAK 26(14Q24.3) WILD-TYPE 329 44 0.0 - 211.2 (15.4)

Figure S28.  Get High-res Image Gene #47: 'del_14q24.3' versus Clinical Feature #1: 'Time to Death'

'del_19q13.41' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.004

Table S29.  Gene #49: 'del_19q13.41' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 28(19Q13.41) MUTATED 46 49 132
DEL PEAK 28(19Q13.41) WILD-TYPE 113 58 32

Figure S29.  Get High-res Image Gene #49: 'del_19q13.41' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_19q13.42' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.004

Table S30.  Gene #50: 'del_19q13.42' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 159 107 164
DEL PEAK 29(19Q13.42) MUTATED 49 52 133
DEL PEAK 29(19Q13.42) WILD-TYPE 110 55 31

Figure S30.  Get High-res Image Gene #50: 'del_19q13.42' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'del_22q13.31' versus 'Time to Death'

P value = 0.000612 (logrank test), Q value = 0.24

Table S31.  Gene #51: 'del_22q13.31' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 427 75 0.0 - 211.2 (15.9)
DEL PEAK 30(22Q13.31) MUTATED 61 23 0.1 - 156.2 (18.0)
DEL PEAK 30(22Q13.31) WILD-TYPE 366 52 0.0 - 211.2 (15.4)

Figure S31.  Get High-res Image Gene #51: 'del_22q13.31' versus Clinical Feature #1: 'Time to Death'

Methods & Data
Input
  • Copy number data file = transformed.cor.cli.txt

  • Clinical data file = LGG-TP.merged_data.txt

  • Number of patients = 430

  • Number of significantly focal cnvs = 52

  • Number of selected clinical features = 8

  • Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)